Abstract: The present invention provides phenyl urea and phenyl thiourea derivatives which are non-peptide antagonists of human orexin receptors, in particular orexin-1 receptors, of formula (I)
in which:
Z represents oxygen or sulfur; and R1 to R7 represent various substituent groups; and pharmaceutically acceptable salts thereof. In particular, these compounds are of potential use in the treatment of obesity including obesity observed in Type 2(non-insulin-dependent) diabetes patients and/or sleep disorders.
Type:
Grant
Filed:
April 29, 2002
Date of Patent:
March 2, 2004
Assignee:
SmithKline Beecham p.l.c.
Inventors:
Steven Coulton, Amanda Johns, Roderick Alan Porter